Medy-Tox Inc.
Biopharmaceutical firm developing botulinum toxins, HA fillers, and dermocosmetics.
086900 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086900008
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청원군 오창읍 각리1길 78 (주)메디톡스, 청원군
- Sector:
- Manufacturing
Description
Medy-Tox Inc. is a biopharmaceutical company focused on the research, development, and commercialization of biologic products. Its primary offerings are centered on botulinum toxin type A (BTX-A) formulations, including Neuronox®, INNOTOX®, Coretox®, and NEWLUX®, which are used for both aesthetic and therapeutic applications. The company is noted for developing the world's first liquid-injectable botulinum toxin. In addition to its toxin portfolio, Medy-Tox manufactures and markets a line of hyaluronic acid (HA) dermal fillers, such as Neuramis®, Atiere, and Potenfill. The company's product range also extends to dermocosmetics under the NEURADERM brand.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-06 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.0 KB | ||
| 2024-06-28 00:00 |
기타시장안내 (업종변경 안내)
|
Korean | 4.7 KB | ||
| 2024-06-26 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.1 KB | ||
| 2024-06-14 00:00 |
투자판단관련주요경영사항 (제조판매중지명령 등 취소 청구 소송 항소심 판결 및 상고의 건)
|
Korean | 10.4 KB | ||
| 2024-05-16 00:00 |
분기보고서 (2024.03)
|
Korean | 1.4 MB | ||
| 2024-05-10 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.5 KB | ||
| 2024-04-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.0 KB | ||
| 2024-03-29 00:00 |
정기주주총회결과
|
Korean | 19.9 KB | ||
| 2024-03-21 00:00 |
감사보고서제출
|
Korean | 26.6 KB | ||
| 2024-03-21 00:00 |
사업보고서 (2023.12)
|
Korean | 2.3 MB | ||
| 2024-03-14 00:00 |
주주총회소집공고
|
Korean | 134.5 KB | ||
| 2024-03-14 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.8 KB | ||
| 2024-03-07 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.8 KB | ||
| 2024-03-07 00:00 |
주주총회소집결의
|
Korean | 11.0 KB | ||
| 2024-02-26 00:00 |
투자판단관련주요경영사항 (비동물성 액상형 보툴리눔톡신제제, 일부 자료 미비로 미국 FDA 품목 허가 신청(BLA) 거…
|
Korean | 7.9 KB |
Automate Your Workflow. Get a real-time feed of all Medy-Tox Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medy-Tox Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medy-Tox Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
